Daniel Bruetman
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 13
- Lung Cancer Research Studies 10
-
- Lung Cancer Treatments and Mutations 11
- Lung Cancer Diagnosis and Treatment 5
- Co-authors
- Nasser H. Hanna (10 shared papers)William B. Fisher (9 shared papers)Rafat Ansari (8 shared papers)Ramaswamy Govindan (8 shared papers)Constantin T. Yiannoutsos (3 shared papers)N. M. Chowhan (3 shared papers)Cynthia S. Johnson (3 shared papers)Sreenivasa Nattam (2 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Journal of Thoracic Oncology (2 papers)Molecular Cancer Therapeutics (1 paper)Annals of Oncology (1 paper)Medical and Pediatric Oncology (1 paper)
- Partner nations
- United States
In The Last Decade
Daniel Bruetman
15 papers receiving 521 citations
Peers
Comparison fields: 5 of 34
- Pulmonary and Respiratory Medicine 462
- Oncology 317
- Otorhinolaryngology 47
- Radiation 61
- Radiology, Nuclear Medicine and Imaging 63
Countries citing papers authored by Daniel Bruetman
This map shows the geographic impact of Daniel Bruetman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Bruetman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Bruetman more than expected).
Fields of papers citing papers by Daniel Bruetman
This network shows the impact of papers produced by Daniel Bruetman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Bruetman. The network helps show where Daniel Bruetman may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Bruetman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 341 | |
| 2 | 2011 | 58 | |
| 3 | 2007 | 41 | |
| 4 | 2009 | 25 | |
| 5 | 2008 | 19 | |
| 6 | 2006 | 12 | |
| 7 | 2006 | 8 | |
| 8 | 2007 | 6 | |
| 9 | 2008 | 5 | |
| 10 | 2006 | 4 | |
| 11 | A phase-I study of 90Y-hPAM4 (humanized anti-MUC1 monoclonal antibody) in patients with unresectable and metastatic pancreatic cancer | 2007 | 4 |
| 12 | 2013 | 2 | |
| 13 | 2007 | 2 | |
| 14 | 2013 | 2 | |
| 15 | 2018 | 1 | |
| 16 | 1991 | 0 |
About Daniel Bruetman
Daniel Bruetman is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Biotechnology, having authored 16 papers that have together received 530 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (10 papers), Lung Cancer Diagnosis and Treatment (5 papers), Cancer therapeutics and mechanisms (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer Research and Treatments (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper) and Inflammatory mediators and NSAID effects (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (462 citations), Oncology (317 citations), Otorhinolaryngology (47 citations), Radiation (61 citations) and Radiology, Nuclear Medicine and Imaging (63 citations). Daniel Bruetman has collaborated with scholars based in United States. Frequent co-authors include Nasser H. Hanna, William B. Fisher, Rafat Ansari, Ramaswamy Govindan, Constantin T. Yiannoutsos, N. M. Chowhan, Cynthia S. Johnson, Sreenivasa Nattam, Donald Richards and Tim Breen. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Molecular Cancer Therapeutics, Annals of Oncology and Medical and Pediatric Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.